Biotech, Patents, vaccines Luke Timmerman wrote: One of the world’s best-selling vaccines, Merck’s Gardasil, is quietly producing some serious money for an unexpected benefactor—the University of Washington. Thanks to some hard-fought patent litigation from the 1990s that ended up ...

Biotech, VC, Life Sciences Luke Timmerman wrote: There are easier things to do these days than trying to organize a biotech investing conference in Seattle. The local cluster has taken its share of body blows, the weather is usually pretty gray in late winter, and investors aren’t in the mood ...

Biotech, Autoimmune, diabetes Luke Timmerman wrote: Diabetics can’t just quit taking insulin when the economy takes a nosedive. So if you’re the world’s largest producer of insulin for a chronic, and growing, medical condition, your outlook on life isn’t that bad right now. T...